Latest News for: Pharmaceutical sources

Edit

The Alter Pharma Group is Becoming A.forall

Hastings Tribune 27 Sep 2023
Milla Pharmaceutical Inc., a subsidiary of the Alter Pharma Group, is now becoming an A.forall company - The Alter Pharma Group, a group of generic and pharmacy sales companies, is rebranding all its brands and businesses into A.forall ... Milla Pharmaceuticals, now an A.forall company, is proud to be part of this transition ... HEALTH PHARMACEUTICAL.
Edit

Unlocking the Potential: Global Dystonia Drugs Market Set to Grow at 5.3% CAGR by 2027 ...

The Galveston Daily News 27 Sep 2023
The pharmaceutical industry's discovery of highly effective GABAergic agent medications for dystonia treatment is further driving the growth of this segment ... The pharmaceutical industry's global research and development efforts are expected to enhance the effectiveness of dystonia drugs, further driving market growth ... HEALTH PHARMACEUTICAL. SOURCE.
Edit

Revolutionizing Pharmaceutical Supply Chains: SpendEdge's API Supplier Optimization

Victoria Advocate 27 Sep 2023
27, 2023 /PRNewswire/ -- The pharmaceutical industry demands precision and reliability in its supply chains to ensure the availability of life-saving medications ... Client Overview.�Our client, a leading pharmaceutical company, grappled with delayed API deliveries and regulatory non-compliance among some API suppliers ... SOURCE SpendEdge.
Edit

CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL ...

Longview News-Journal 27 Sep 2023
"We are therefore pleased to have initiated this Phase 3 pivotal clinical trial of Cantex's azeliragon to determine its effect on preventing the kidney and lung complications that are a major source of morbidity and mortality from severe COVID-19 infection." ... About Cantex Pharmaceuticals, Inc ... SOURCE Cantex Pharmaceuticals, Inc.
Edit

Advancements in Controlled Release Systems: Sustained Drug Release and Targeted Delivery Revolutionize Patient Care - ResearchAndMarkets.com

The Galveston Daily News 27 Sep 2023
This significant growth is driven by the increasing adoption of controlled release formulations by pharmaceutical companies seeking to combat generic competition ... ResearchAndMarkets.com is the world's leading source for international market research reports and market data ... HEALTH PHARMACEUTICAL. SOURCE.
Edit

Leading Epidemiologist Wendy Cheng Joins BRG's Healthcare Practice as Managing Director

Longview News-Journal 27 Sep 2023
Cheng will support pharmaceutical clients in ... "With her impressive academic background and over a decade of experience working with the pharmaceutical industry, she excels at sourcing viable, high-grade data to assess the safety of medications ... SOURCE Berkeley Research Group, LLC.
Edit

Prospection Appoints Technology-industry Veteran and Commercialization Leader Daniel West to Chief Executive Officer

The Galveston Daily News 27 Sep 2023
Prospection also brings deep technology- and pharmaceutical-industry experience to its Board of Directors with the appointment of Craig Jones as its Chairperson and Bruce Goodwin as a Non-Executive Director ... Prospection pioneers patient-centric intelligence, illuminating patient care’s impact on market share for pharmaceutical brands ... SOURCE.
Edit

Azurity Pharmaceuticals Acquires Slayback Pharma

Longview News-Journal 27 Sep 2023
27, 2023 /PRNewswire/ -- Azurity Pharmaceuticals, Inc.�("Azurity") is pleased to announce the closing of its acquisition of Slayback Pharma LLC ("Slayback") today from existing investors including KKR, a leading global investment firm, and Everstone Capital ... About Azurity Pharmaceuticals. ... SOURCE Azurity Pharmaceuticals.
Edit

Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on its Anti-aVb8 Monoclonal Antibody (CRB-601) at the ...

Longview News-Journal 27 Sep 2023
27, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc ... Corbus Pharmaceuticals Holdings, Inc ... Corbus Pharmaceuticals ... SOURCE Corbus Pharmaceuticals.
Edit

Levine Leichtman Capital Partners Portfolio Company Technical Safety Services Acquires Controlled Environment Management

The Galveston Daily News 27 Sep 2023
Based in Gilbert, Arizona, CEM is a provider of controlled environment testing, validation, certification, and calibration services required in high-performance, regulated pharmaceutical, biotechnology, and healthcare settings ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230927435382/en/ ... SOURCE.
Edit

Ionis enters agreement with Roche for two novel RNA-targeted programs for Alzheimer's disease and Huntington's disease

Longview News-Journal 27 Sep 2023
27, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc.�(Nasdaq ... About�Ionis Pharmaceuticals, Inc ... In this press release, unless the context requires otherwise, "Ionis," "Company," "we," "our," and "us" refers to�Ionis Pharmaceuticals and its subsidiaries ... SOURCE Ionis Pharmaceuticals, Inc.
Edit

Milestone Pharmaceuticals Announces Etripamil AFib-RVR Study is Selected for Featured Science Presentation at the American ...

Longview News-Journal 27 Sep 2023
27, 2023 /PRNewswire/ -- Milestone Pharmaceuticals Inc ... We're optimistic that the data will demonstrate etripamil's potential to meet this goal for patients who have limited options to self-manage their disease," said David Bharucha, M.D., Ph.D., F.A.C.C., Chief Medical Officer of Milestone Pharmaceuticals ... SOURCE Milestone Pharmaceuticals, Inc.
Edit

Claudin 18.2-Targeted Immunotherapy Research Report 2023: Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business ...

The Galveston Daily News 27 Sep 2023
Rest assured, all information is rigorously sourced, with 107 scientific references, including conference abstracts, posters, presentations, full papers, and hyperlinks to corporate sources such as press releases, presentations, annual reports, SEC disclosures, and website content ... 9.3.5 Jiangsu Hengrui Pharmaceuticals ... 9.4.9 Qilu Pharmaceutical.
Edit

Venatorx Pharmaceuticals to Present at IDWeek 2023

The Galveston Daily News 27 Sep 2023
About Venatorx Pharmaceuticals, Inc. Venatorx is a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with difficult-to-treat drug resistant gram-negative bacterial infections and viral infections ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230927557949/en/ ... SOURCE.
Edit

SaNOtize’s Board Appoints Steven Basta as New Chief Executive Officer

The Joplin Globe 27 Sep 2023
View the full release here ... is a pharmaceutical company based in Vancouver, BC, commercializing the multi-faceted antimicrobial properties of a liquid producing nitric oxide ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230925232677/en/ ... HEALTH CLINICAL TRIALS RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY. SOURCE ... .

Most Viewed

In this photo released by Azerbaijan's border guard service on Wednesday, Sept. 27, 2023, Azerbaijan's border guard officers pose with detained Ruben Vardanyan, center, in Nagorno-Karabakh. Azerbaijan says it has detained the former head of Nagorno-Karabakh's separatist government as he tried to cross into Armenia following Azerbaijan's 24-hour blitz last week to reclaim control of the enclave. The arrest of Ruben Vardanyan was announced by Azerbaijan's border guard service.
AP / Azerbaijan's border guard service via AP
File - Donald Trump speaking with attendees at the 2023 Turning Point Action Conference in West Palm Beach, Florida
Creative Commons / Gage Skidmore https://creativecommons.org/licenses/by-sa/2.0/deed.en
×